CRON.TO
Cronos Group Inc
Price:  
2.43 
CAD
Volume:  
66,551.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRON.TO EV/EBITDA

-48.3%
Upside

As of 2025-04-22, the EV/EBITDA ratio of Cronos Group Inc (CRON.TO) is 5.09. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CRON.TO's latest enterprise value is -252.81 mil CAD. CRON.TO's TTM EBITDA according to its financial statements is -49.70 mil CAD. Dividing these 2 quantities gives us the above CRON.TO EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 4.5x - 19.0x 11.4x
Forward P/E multiples 4.8x - 14.6x 9.0x
Fair Price 2.22 - 0.48 1.26
Upside -8.6% - -80.4% -48.3%
2.43 CAD
Stock Price
1.26 CAD
Fair Price

CRON.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-04-21 -1.18
2025-04-17 -1.56
2025-04-16 -1.72
2025-04-15 -1.25
2025-04-14 -1.10
2025-04-11 -1.56
2025-04-10 -0.71
2025-04-09 -1.41
2025-04-08 -0.48
2025-04-07 -1.10
2025-04-04 -1.56
2025-04-03 -2.11
2025-04-02 -2.88
2025-04-01 -2.57
2025-03-31 -2.81
2025-03-28 -2.57
2025-03-27 -2.96
2025-03-26 -2.65
2025-03-25 -2.81
2025-03-24 -3.66
2025-03-21 -2.73
2025-03-20 -2.88
2025-03-19 -3.27
2025-03-18 -3.27
2025-03-17 -3.58
2025-03-14 -3.66
2025-03-13 -3.58
2025-03-12 -3.66
2025-03-11 -3.89
2025-03-10 -4.20
2025-03-07 -4.67
2025-03-06 -4.90
2025-03-05 -5.29
2025-03-04 -5.36
2025-03-03 -4.74
2025-02-28 -5.60
2025-02-27 -4.90
2025-02-26 -3.27
2025-02-25 -3.58
2025-02-24 -3.89
2025-02-21 -4.28
2025-02-20 -3.89
2025-02-19 -4.28
2025-02-18 -4.05
2025-02-14 -4.43
2025-02-13 -4.74
2025-02-12 -4.59
2025-02-11 -4.51
2025-02-10 -4.36
2025-02-07 -4.28